Neuropediatrics 2014; 45(02): 117-119
DOI: 10.1055/s-0033-1349225
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Glucose Transporter Type 1 Deficiency Syndrome Effectively Treated with Modified Atkins Diet

Edda Haberlandt
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Daniela Karall
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Veronika Jud
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Sara Sigl Baumgartner
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Sibylle Zotter
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Kevin Rostasy
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Matthias Baumann
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
,
Sabine Scholl-Buergi
1   Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria
› Author Affiliations
Further Information

Publication History

15 June 2012

06 May 2013

Publication Date:
25 July 2013 (online)

Abstract

This is a report on the successful treatment of a 6-year-old girl with genetically proven glucose transporter type 1 deficiency syndrome (GLUT1-DS) with modified Atkins diet (MAD). GLUT1-DS is an inborn disorder of glucose transport across the blood–brain barrier, which leads to energy deficiency of the brain with a broad spectrum of neurological symptoms including therapy-resistant epilepsy. Usually classical ketogenic diet (KD) is the standard treatment for patients with GLUT1-DS. Treatment with MAD, a variant of KD, for an observation period of 17 months resulted in improvement of seizures, alertness, cognitive abilities, and electroencephalography in this patient.

 
  • References

  • 1 Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia 2008; 49 (Suppl. 08) 37-41
  • 2 De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood–brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325 (10) 703-709
  • 3 Wang D, Pascual JM, Yang H , et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005; 57 (1) 111-118
  • 4 Ito S, Oguni H, Ito Y, Ishigaki K, Ohinata J, Osawa M. Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev 2008; 30 (3) 226-228
  • 5 Ito Y, Oguni H, Ito S, Oguni M, Osawa M. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 2011; 53 (7) 658-663
  • 6 Parolin G, Drigo P, Toldo I , et al. Pre- and postprandial electroencephalography in glucose transporter type 1 deficiency syndrome: an illustrative case to discuss the concept of carbohydrate responsiveness. J Child Neurol 2011; 26 (1) 103-108
  • 7 Ito Y, Gertsen E, Oguni H , et al. Clinical presentation, EEG studies, and novel mutations in two cases of GLUT1 deficiency syndrome in Japan. Brain Dev 2005; 27 (4) 311-317
  • 8 von Moers A, Brockmann K, Wang D , et al. EEG features of glut-1 deficiency syndrome. Epilepsia 2002; 43 (8) 941-945
  • 9 Leen WG, Klepper J, Verbeek MM , et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133 (Pt 3) 655-670